Sign Up Today and Learn More About Autobahn Therapeutics Stock
Invest in or calculate the value of your shares in Autobahn Therapeutics or other pre-IPO companies through EquityZen's platform.
Autobahn Therapeutics Stock (AUTT)
Autobahn Therapeutics is a developer of regenerative medicines to restore hope for people affected by CNS disorders.
About Autobahn Therapeutics Stock
Founded
2017
Headquarters
San Diego, CA, US
Industries
Software, Artificial Intelligence, Science and Engineering
Autobahn Therapeutics Press Mentions
Stay in the know about the latest news on Autobahn Therapeutics
Autobahn’s elunetirom receives FDA fast track designation to treat adjunctive bipolar
pharmaceutical-technology • May 28, 2026
Autobahn Therapeutics Announces U.S. FDA Fast Track Designation for Elunetirom, a CNS-Directed Thyroid Hormone Receptor Agonist, for the Adjunctive Treatment of Bipolar Depression
businesswire • May 26, 2026
Autobahn Therapeutics Announces U.S. FDA Fast Track Designation for Elunetirom, a CNS-Directed Thyroid Hormone Receptor Agonist, for the Adjunctive Treatment of Bipolar Depression
biospace • May 26, 2026
Autobahn Therapeutics Presents New Preclinical Data at ASCP Annual Meeting Demonstrating Elunetirom Drives Robust Bioenergetic and Neuroplastic Improvements in Neuronal Cultures
sdbn • May 23, 2026
Autobahn Therapeutics Presents New Preclinical Data at ASCP Annual Meeting Demonstrating Elunetirom Drives Robust Bioenergetic and Neuroplastic Improvements in Neuronal Cultures
businesswire • May 20, 2026
Autobahn Therapeutics Management
Leadership team at Autobahn Therapeutics
General Counsel & SVP, Administration
John Borkholder
Chairman and CEO
Kevin Finney
Join now and verify your accreditation status to gain access to:
- Autobahn Therapeutics Current Valuation
- Autobahn Therapeutics Stock Price
- Autobahn Therapeutics Management
- Available deals in Autobahn Therapeutics and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Autobahn Therapeutics Cap Table and Funding History by Share Class and Liquidity Preferences
- Autobahn Therapeutics Revenue and Financials
- Autobahn Therapeutics Highlights
- Autobahn Therapeutics Business Model
- Autobahn Therapeutics Risk Factors
- Autobahn Therapeutics Research Report from SACRA Research
Trading Autobahn Therapeutics Stock
How to invest in Autobahn Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like Autobahn Therapeutics through EquityZen funds. These investments are made available by existing Autobahn Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process for buying Pre-IPO Shares.
How to sell Autobahn Therapeutics stock?
Shareholders can sell their Autobahn Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 460K accredited investors interested in buying private company stock. Learn more about the Shareholder liquidity process.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. See more information on Express Deals and pre-IPO exit information.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 54K private placements completed across 500+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
